bpc 157 peptides side effects 10 questions to ask your doctor about Peptide Therapy in Brandon &

Common Mild Reactions Local irritation where the peptide was injected (minor redness or tenderness) Occasional dizziness or fatigue shortly after use Typically mild and short-lived Potential Risks Not FDA-approved for Lyme disease or any other condition Contraindicated in active cancer due to its angiogenesis-promoting properties Should be avoided during pregnancy or breastfeeding Take Precautions with Medical Guidance Since its administered via injection and isnt regulated for Lyme treatment, a professional Lyme disease expert should guide your dosing

Individuals taking prescription medications, particularly those affecting blood sugar or blood pressure, should consult healthcare providers before combining treatments

That is the core distinction

And that was it."